Mitsubishi Chemical Group to Strengthen Presence in Field of Regenerative Medicine by Acquiring Clio Inc.

Seiichi Kiso, President and CEO, Life Science Institute Life Science Institute Inc. (LSII), a subsidiary of Mitsubishi Chemical Holdings, will acquire Clio Inc., a bioventure engaged in studies on multilineage-differentiating stress-enduring (Muse) cells for their use in the field of...read more